دورية أكاديمية
أعرض في EDS

Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.

التفاصيل البيبلوغرافية
العنوان: Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.
المؤلفون: Hack CC; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Hackl J; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Hüttner NBM; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Langemann H; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Schwitulla J; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Dietzel-Drentwett S; 2 Hospital Bayreuth GmbH, Bayreuth, Germany., Fasching PA; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Beckmann MW; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Theuser AK; 1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
المصدر: Integrative cancer therapies [Integr Cancer Ther] 2018 Sep; Vol. 17 (3), pp. 941-951. Date of Electronic Publication: 2018 May 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Thousand Oaks, CA : Sage Publications, c2002-
مواضيع طبية MeSH: Quality of Life*, Breast Neoplasms/*therapy , Integrative Oncology/*adverse effects, Adult ; Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/psychology ; Cross-Sectional Studies ; Drug-Related Side Effects and Adverse Reactions/therapy ; Female ; Humans ; Integrative Medicine/methods ; Integrative Oncology/methods ; Middle Aged ; Retrospective Studies ; Self Report
مستخلص: Purpose: Although the demand from patients for integrative medicine is increasing, complementary medicine services are still quite heterogeneous and have not been incorporated into clinical routine. The aim of this study was to systematically evaluate improvements in side effects and quality of life associated with a hospital-based integrative medicine program in the modern breast cancer patient care setting.
Methods: In a cross-sectional study, integrative health counseling and treatment were evaluated in women with breast cancer. Over a 15-month period, data for 75 patients from an integrative medicine consultancy service with standardized operating procedures were collected at the University Breast Center for Franconia. At baseline, the patients answered a questionnaire on their medical history, symptoms, and the treatment goals they were hoping to achieve with integrative medicine. In the follow-up, patient-reported outcomes related to side effects of conventional cancer treatment and patients' quality of life were analyzed.
Results: Among 60 patients with the therapy goal of reducing the side effects of conventional treatment, 46 (76.7%) were successful. Among 57 patients hoping to improve disease-related quality of life, 46 (82%) reported success. Whereas patients with metastatic disease achieved a reduction in the side effects of conventional therapy, quality-of-life improvements were predominantly achieved by patients with a good treatment prognosis.
Conclusions: Breast cancer patients benefit from the counseling and treatment provided with integrative medicine in all phases of tumor disease. Integrative treatment services should be included as part of patient care in clinical routine work to offer patients the maximum quality of care and safety with complementary therapies.
References: Radiol Technol. 2014 Jan-Feb;85(3):297M-319M; quiz 320M-323M. (PMID: 24395910)
Surg Clin North Am. 2013 Apr;93(2):493-9. (PMID: 23464698)
Breast Care (Basel). 2014 Feb;9(1):60-3. (PMID: 24803889)
Integr Cancer Ther. 2013 Jul;12(4):276-90. (PMID: 23632236)
Clin Transl Oncol. 2015 Mar;17(3):180-96. (PMID: 24894838)
Curr Oncol. 2012 Oct;19(5):e343-52. (PMID: 23144582)
Oncol Res Treat. 2014;37(1-2):49-53. (PMID: 24613909)
In Vivo. 2013 Nov-Dec;27(6):869-71. (PMID: 24292594)
Complement Ther Med. 2013 Aug;21(4):417-29. (PMID: 23876573)
Psychooncology. 2013 Jul;22(7):1457-65. (PMID: 22961994)
Integr Cancer Ther. 2017 Jun;16(2):165-175. (PMID: 27627986)
Semin Oncol. 2011 Jun;38(3):394-402. (PMID: 21600369)
J Soc Integr Oncol. 2009 Summer;7(3):85-120. (PMID: 19706235)
Arch Gynecol Obstet. 2018 Jul;298(1):147-156. (PMID: 29704060)
Breast Cancer Res Treat. 2010 Jan;119(1):105-10. (PMID: 19641989)
Arch Gynecol Obstet. 2014 Jul;290(1):135-41. (PMID: 24496514)
Ann Oncol. 2013 Sep;24(9):2206-23. (PMID: 23917950)
Breast Care (Basel). 2014 Jul;9(3):154-60. (PMID: 25177256)
J Clin Oncol. 2002 Sep 15;20(18 Suppl):34S-8S. (PMID: 12235222)
Anticancer Res. 2014 Feb;34(2):943-8. (PMID: 24511037)
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):null. (PMID: 29140493)
Eur J Cancer. 2012 Nov;48(17):3133-9. (PMID: 22633625)
Geburtshilfe Frauenheilkd. 2015 Jul;75(7):675-682. (PMID: 26257404)
CA Cancer J Clin. 2017 May 6;67(3):194-232. (PMID: 28436999)
Support Care Cancer. 2012 Jul;20(7):1479-89. (PMID: 21818642)
Eur J Cancer Care (Engl). 2014 Mar;23(2):173-9. (PMID: 23889081)
J Natl Cancer Inst Monogr. 2014 Nov;2014(50):346-58. (PMID: 25749602)
Cancer Treat Rev. 2008 Nov;34(7):640-55. (PMID: 18514425)
Patient Educ Couns. 2007 Jun;66(3):311-8. (PMID: 17331692)
Geburtshilfe Frauenheilkd. 2015 Apr;75(4):377-383. (PMID: 26028695)
Integr Cancer Ther. 2012 Sep;11(3):187-203. (PMID: 22019489)
Arch Gynecol Obstet. 1996;258(2):81-8. (PMID: 8779615)
Support Care Cancer. 2015 Dec;23(12):3411-9. (PMID: 25752885)
Psychooncology. 2011 Nov;20(11):1211-20. (PMID: 20878646)
J Cancer Res Clin Oncol. 2013 Sep;139(9):1515-22. (PMID: 23832609)
Aliment Pharmacol Ther. 2004 Dec;20(11-12):1279-87. (PMID: 15606389)
J Clin Oncol. 2007 Jun 10;25(17):2345-51. (PMID: 17557947)
Cancer Causes Control. 2013 Jan;24(1):181-91. (PMID: 23184120)
Support Care Cancer. 2007 Nov;15(11):1277-1284. (PMID: 17333294)
Breast Cancer Res Treat. 2015 Jan;149(2):449-60. (PMID: 25555830)
Med Oncol. 2011 Sep;28(3):753-65. (PMID: 20411366)
Cancer J. 2006 Sep-Oct;12(5):425-31. (PMID: 17034678)
J Clin Oncol. 2014 Jul 20;32(21):2255-69. (PMID: 24868023)
Clin J Oncol Nurs. 2010 Aug;14(4):E45-55. (PMID: 20682492)
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:219-24. (PMID: 16515594)
Breast. 2008 Dec;17(6):640-5. (PMID: 18595700)
Support Care Cancer. 2006 Mar;14(3):260-7. (PMID: 16143871)
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004845. (PMID: 19370613)
CA Cancer J Clin. 2005 Mar-Apr;55(2):109-16. (PMID: 15761079)
Breast Cancer Res Treat. 2006 Feb;95(3):199-209. (PMID: 16254687)
فهرسة مساهمة: Keywords: breast cancer; complementary and alternative medicine; integrative medicine; oncology; patient care; quality of life; side effect management
تواريخ الأحداث: Date Created: 20180531 Date Completed: 20190419 Latest Revision: 20190419
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6142097
DOI: 10.1177/1534735418777883
PMID: 29845888
قاعدة البيانات: MEDLINE
الوصف
تدمد:1552-695X
DOI:10.1177/1534735418777883